Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Market Wrap: Men's Wearhouse/Jos. A. Bank Strike Deal; Fuel Cell Stocks Pop, Drop; Bye, Bye Fannie and Freddie?
- Streetinsider.com After-Hours Movers 03/11: (OXGN) (PRMW) (PAY) Higher; (MX) (KTOS) (PLUG) Lower
- Men's Wearhouse (MW) to Acquire Jos. A. Bank (JOSB) for $65/Share Cash
- The End of Fannie (FNMA) and Freddie (FMCC)?
- Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q4 EPS; Issues Mixed Q1, FY14 Outlook
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
You May Also Be Interested In
- OXiGENE (OXGN) Halted as News is Disseminated
- Synta Pharma (SNTA) Ganetespib Selected for Study in I-SPY 2 TRIAL
- OXiGENE (OXGN) to Resume Trading at 4:15PM
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!